Search Results - "EDER, Matthias"

Refine Results
  1. 1

    [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer by Hennrich, Ute, Eder, Matthias

    Published in Pharmaceuticals (Basel, Switzerland) (20-10-2022)
    “…In March 2022, [177Lu]Lu-PSMA-617 (PluvictoTM) was approved by the FDA for the treatment of prostate cancer patients. Until now, the approval has been limited…”
    Get full text
    Journal Article
  2. 2

    A Simple Expression for the Screening of Excitonic Couplings between Chlorophylls as Inferred for Photosystem I Trimers by Eder, Matthias, Renger, Thomas

    “…The Coulomb coupling between transition densities of the pigments in photosynthetic pigment-protein complexes, termed excitonic coupling, is a key factor for…”
    Get full text
    Journal Article
  3. 3

    New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy by Haberkorn, Uwe, Eder, Matthias, Kopka, Klaus, Babich, John W, Eisenhut, Michael

    Published in Clinical cancer research (01-01-2016)
    “…Key issues for prostate cancer patients are the detection of recurrent disease and the treatment of metastasized cancer. Early detection is a major challenge…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients by Baier, Claas, Linke, Lena, Eder, Matthias, Schwab, Frank, Chaberny, Iris Freya, Vonberg, Ralf-Peter, Ebadi, Ella

    Published in PloS one (24-01-2020)
    “…Non-implanted central vascular catheters (CVC) are frequently required for therapy in hospitalized patients with hematological malignancies or solid tumors…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors by Benešová, Martina, Bauder-Wüst, Ulrike, Schäfer, Martin, Klika, Karel D, Mier, Walter, Haberkorn, Uwe, Kopka, Klaus, Eder, Matthias

    Published in Journal of medicinal chemistry (10-03-2016)
    “…Since prostate-specific membrane antigen (PSMA) is up-regulated in nearly all stages of prostate cancer (PCa), PSMA can be considered as a viable diagnostic…”
    Get full text
    Journal Article
  9. 9

    Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing by Afshar-Oromieh, Ali, Hetzheim, Henrik, Kübler, Wolfgang, Kratochwil, Clemens, Giesel, Frederik L., Hope, Thomas A., Eder, Matthias, Eisenhut, Michael, Kopka, Klaus, Haberkorn, Uwe

    “…Purpose The clinical introduction of 68 Ga-PSMA-11 (“HBED-CC”) ligand targeting the prostate-specific membrane antigen (PSMA) has been regarded as a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    QTL mapping of volatile compound production in Saccharomyces cerevisiae during alcoholic fermentation by Eder, Matthias, Sanchez, Isabelle, Brice, Claire, Camarasa, Carole, Legras, Jean-Luc, Dequin, Sylvie

    Published in BMC genomics (01-03-2018)
    “…The volatile metabolites produced by Saccharomyces cerevisiae during alcoholic fermentation, which are mainly esters, higher alcohols and organic acids, play a…”
    Get full text
    Journal Article
  12. 12

    [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer by Hennrich, Ute, Eder, Matthias

    Published in Pharmaceuticals (Basel, Switzerland) (23-07-2021)
    “…For the positron emission tomography (PET) imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used…”
    Get full text
    Journal Article
  13. 13

    Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer by Eder, Matthias, Neels, Oliver, Müller, Miriam, Bauder-Wüst, Ulrike, Remde, Yvonne, Schäfer, Martin, Hennrich, Ute, Eisenhut, Michael, Afshar-Oromieh, Ali, Haberkorn, Uwe, Kopka, Klaus

    Published in Pharmaceuticals (Basel, Switzerland) (30-06-2014)
    “…The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last…”
    Get full text
    Journal Article
  14. 14

    Cacna1c deficiency in forebrain glutamatergic neurons alters behavior and hippocampal plasticity in female mice by Loganathan, Srivaishnavi, Menegaz, Danusa, Delling, Jan Philipp, Eder, Matthias, Deussing, Jan M.

    Published in Translational psychiatry (06-10-2024)
    “…CACNA1C , coding for the α1 subunit of L-type voltage-gated calcium channel (LTCC) Ca v 1.2, has been associated with multiple psychiatric disorders. Clinical…”
    Get full text
    Journal Article
  15. 15

    Gene Silencing by Small Regulatory RNAs in Mammalian Cells by Scherr, Michaela, Eder, Matthias

    Published in Cell cycle (Georgetown, Tex.) (15-02-2007)
    “…Since some years, activation of RNA interference (RNAi) has been developed into a widely used and powerful biological tool to functionally annotate genomes…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells by Venturini, Letizia, Battmer, Karin, Castoldi, Mirco, Schultheis, Beate, Hochhaus, Andreas, Muckenthaler, Martina U., Ganser, Arnold, Eder, Matthias, Scherr, Michaela

    Published in Blood (15-05-2007)
    “…Aberrant micro RNA (miRNA) expression has been described in human malignancies including B-cell lymphomas. We here report BCR-ABL– and c-MYC–dependent…”
    Get full text
    Journal Article
  19. 19

    Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer by Eder, Matthias, Schäfer, Martin, Bauder-Wüst, Ulrike, Haberkorn, Uwe, Eisenhut, Michael, Kopka, Klaus

    Published in The Prostate (01-05-2014)
    “…BACKGROUND It has recently been reported that metastases of prostate cancer usually show highly heterogeneous or partly lost prostate‐specific membrane antigen…”
    Get full text
    Journal Article
  20. 20